NTHI
Neonc Technologies Holdings, Inc.Healthcare·Biotechnology
$4.64
$93M market cap
Revenue
$0.0M
Free Cash Flow
$-10.6M
Rev Growth
+0.0%
FCF Margin
0.0%
P/FCF
--
EV/FCF
--
Fwd EV/EBITDA
--
Fair Value
--
Upside
--
Neonc Technologies Holdings, Inc. develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los An
2-Year Price History
$5.34-40.9%
Quarterly Financials & Projections
Quarterly Waterfall ($ M)
| Period | Rev | EBITDA | OpIn | NI | OCF | FCF | CapEx | Cash | Debt | Shares | ROIC | IntCov | EV/EBITDA | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Act | 2026-Q1 | 0.0 | -7.0 | -7.1 | -8.8 | -7.0 | -7.0 | -0.0 | 0.1 | 0.4 | 23.3 | -610.5% | -6.0x | -- |
| Act | 2025-Q4 | 0.0 | -14.3 | -13.7 | -15.5 | -3.6 | -3.6 | -0.0 | 0.1 | 6.3 | 19.2 | -867.7% | -29.8x | -- |
Valuation & Metrics
Market Stats
Price$4.64
Market Cap$93M
Enterprise Value$93M
P/S Ratio0.0x
P/FCF--
EV/FCF--
FCF Margin (TTM)0.0%
FCF Yield-11.4%
Dividend Yield (TTM)--
Annual Dilution0.0%
CurrencyUSD
TTM Financial Snapshot
Revenue$0.0M
Net Income$-24.3M
Free Cash Flow$-10.6M
Revenue Growth (YoY)+0.0%
EBITDA Margin0.0%
Net Margin0.0%
FCF Margin0.0%
CapEx % of Revenue0.0%
SBC % of Revenue0.0%
ROIC-739.1%
WC Change % Rev0.0%
Interest Coverage-12.9x
Forward Outlook & Risk
Short Interest
Short % of Float--
Short Shares0.3M
Days to Cover3.9
Change (vs Prior)-24.5%
Need at least 2 settlement dates for chart
Employees
Headcount8
Revenue / Employee$0
Gross Profit / Employee$-3,998
Cash Runway
0.2months
CRITICAL
Institutional Ownership
Headline & net flow
NEUTRAL
Net flow · —still filing
No float data — flow unavailable.
Ownership composition
Active
14.1%(+13.6% YoY)
17 filers
hedge / family / endowment
Retail funds
—
Fidelity, Schwab, 401(k)
Passive
4.1%(+4.1% YoY)
7 filers
Vanguard, iShares, SPDR
Market makers
0.6%(+0.6% YoY)
2 filers
Citadel, Susquehanna
Insiders
—
Form 4 — latest per insider
ActiveRetail fundsPassiveMarket makersRetail direct
Top holders
| Fund | $ value | Cost basis | Δ QoQ | Δ YoY | α life | Fund AUM |
|---|---|---|---|---|---|---|
| Cinctive Capital Management LP | $10.0M | $7.01 | +$10.0M | +$10.0M | +2.0% | $1.51B |
| BANK OF AMERICA CORP /DE/ | $1.7M | $3.78 | +$78K | +$1.7M | -0.1% | $1.36T |
| VANGUARD CAPITAL MANAGEMENT LLCPassive | $1.5M | $7.01 | +$1.5M | +$1.5M | — | $4.04T |
| BlackRock, Inc.Passive | $1.1M | $8.81 | −$71K | +$1.1M | -0.2% | $5.69T |
| Hudson Bay Capital Management LP | $962K | $7.01 | +$1.0M | +$962K | +1.9% | $15.12B |
| GEODE CAPITAL MANAGEMENT, LLCPassive | $890K | $8.97 | +$47K | +$890K | +2.3% | $1.61T |
| MILLENNIUM MANAGEMENT LLC | $836K | $5.85 | +$554K | +$836K | -0.5% | $127.40B |
| SUSQUEHANNA INTERNATIONAL GROUP, LLPMM | $638K | $7.01 | +$638K | +$638K | -0.6% | $77.14B |
| VANGUARD FIDUCIARY TRUST COPassive | $393K | $7.01 | +$393K | +$393K | — | $395.83B |
| MORGAN STANLEY | $364K | $7.21 | +$306K | +$364K | -0.3% | $1.65T |
| 683 Capital Management, LLC | $351K | $8.27 | −$24K | +$351K | -2.2% | $1.02B |
| Westmount Partners, LLC | $304K | $3.82 | +$0 | +$185K | -0.1% | $405M |
| STATE STREET CORPPassive | $303K | $9.01 | +$0 | +$303K | -0.2% | $2.89T |
| GOLDMAN SACHS GROUP INC | $249K | $7.54 | +$144K | +$249K | -0.2% | $760.93B |
| NORTHERN TRUST CORPPassive | $163K | $8.99 | +$0 | +$163K | -0.2% | $755.34B |
| ROYAL BANK OF CANADA | $117K | $4.82 | −$0 | −$13K | -0.2% | $526.36B |
| HCR Wealth Advisors | $105K | $3.57 | +$0 | +$105K | -2.0% | $964M |
| MARSHALL WACE, LLP | $88K | $7.01 | +$88K | +$88K | +0.6% | $92.71B |
| HRT FINANCIAL LP | $80K | $7.01 | +$80K | +$80K | -0.6% | $39.46B |
| BARCLAYS PLC | $57K | $8.28 | −$8K | +$57K | -0.1% | $279.69B |
Cost basis is a volume-weighted estimate from accumulation periods within our 13F history; holders who built their position before our window started will show a stale basis. % above the cost basis is the unrealized gain at the current price.
Trading behavior
Smart-money alpha (lifetime, %/qtr)BULLISH
Holders
+1.30%
avg per quarter
Holders (ex-self)
+1.31%
excl. this stock
Buyers (this Q)
+1.73%
13 buyers · $0.01B in
Sellers (this Q)
-1.41%
5 sellers · $0.00B out
alpha coverage: 90% of $ has a lifetime-alpha record
Holder behavior on this stocksource: stock
On big dips (−10%+)
+2.2%
how holders react when this stock falls
On quiet Qs
+11.0%
−10% to +10% baseline
On rallies (+10%+)
+43.8%
how they react when this stock rises
Holders' portfolio flow this Q
-8.1%
outflows — trims may be forced
Sellers' portfolio flow this Q
+1.2%
Sellers grew AUM elsewhere — opinionated cut of this stock.
▸ Compare to holder-profile behavior (across all their stocks)
Holder dip (any stock)
-12.8%
Holder mid (any stock)
-16.7%
Holder rally (any stock)
-24.9%
Biggest decreases this quarter
New buyers this quarter
Cinctive Capital Management LP+$0.01Bα+2.0VANGUARD CAPITAL MANAGEMENT LLC+$0.00BHudson Bay Capital Management LP+$0.00Bα+1.9SUSQUEHANNA INTERNATIONAL GROUP, LLP+$0.00Bα-0.6VANGUARD FIDUCIARY TRUST CO+$0.00BMARSHALL WACE, LLP+$0.00Bα+0.6HRT FINANCIAL LP+$0.00Bα-0.6Vanguard Global Advisers, LLC+$0.00B
Top-5 holders · 75.1%
Cinctive Capital Management LP--
BANK OF AMERICA CORP /DE/--
VANGUARD CAPITAL MANAGEMENT LLC--
BlackRock, Inc.--
Hudson Bay Capital Management LP--
Top Holders Over Time
5-year share-count history (top 10 holders by peak, incl. exited) + price
hover the chart for per-quarter detailprice (right axis)
Cinctive Capital Management LP1.4MHighPoint Advisor Group LLC—BANK OF AMERICA CORP /DE/235KHudson Bay Capital Management LP147KMILLENNIUM MANAGEMENT LLC119K683 Capital Management, LLC50KGlobal Retirement Partners, LLC—Westmount Partners, LLC43KMORGAN STANLEY52KGOLDMAN SACHS GROUP INC36K
Analyst Coverage
Analyst Coverage
Price Targets
Last Quarter (3 analysts)$16.0024480.0%
Last Year (3 analysts)$16.0024480.0%
Current Price$4.64
Corporate
Insider Trading (last 12mo)
Open-market only (Form 4 P-Purchase + S-Sale). Excludes grants, option exercises, tax withholding, gifts.
Officers & directors
Buys ($, 12mo)
$22K
2 txns · 2 insiders · 3,100 sh
Sells ($, 12mo)
$0
0 txns · 0 insiders · 0 sh
Major holders (≥10% beneficial owners)
Buys ($, 12mo)
$185K
2 txns · 1 insider · 30,000 sh
Sells ($, 12mo)
$0
0 txns · 0 insiders · 0 sh
Recent transactions
| Date | Side | Insider | Title | Shares | Price | Dollars | Owned $ |
|---|---|---|---|---|---|---|---|
| 2025-11-24 | BUY | Heshmatpour Amir F | director, 10 percent owner, officer: President | 6,000 | $6.51 | $39K | $19.48M |
| 2025-11-21 | BUY | Heshmatpour Amir F | director, 10 percent owner, officer: President | 24,000 | $6.07 | $146K | $18.12M |
| 2025-11-20 | BUY | Neman-Ebrahim Yousha | officer: Chief Clinical Officer | 1,100 | $6.69 | $7K | $898K |
| 2025-05-23 | BUY | Heshmatpour Amir F | director, officer: President | 2,000 | $7.39 | $15K | $13.03M |
Order Flow (FINRA, ~3w lag)
32.7%retail+7.3pp
17.6%dark+2.4pp
week of 2026-04-13
Off-exchange volume from FINRA. Retail = non-ATS (wholesaler PFOF + broker internalization). Dark = ATS (dark-pool crossing networks, institutional). Lit-exchange = remainder.
Filing Risk Analysis
Filing Risk Scores
NEONC TECHNOLOGIES HOLDINGS, INC.: A Masterclass in Insider Enrichment and Toxic Financing
Overall Risk
9/10
Fraud
7/10
Dilution
10/10
Insolvency
10/10
Earnings Overstated
2/10
Hidden Liabilities
7/10
Legal
8/10
Audit Warnings
9/10
Hidden Upside
3/10
Contextually Acceptable
2/10